Autopsy report · NCT01461005
A Postmarket Surveillance Study of the Paradigm Spine Dynamic Stabilization System (DSS)
Cause of deathRegulatory or ethics
“FDA reclassified so all 522 studies were stopped,”
Life of this trial
- Registered 1 month after it had already started.
- Ran for about 5 years before it stopped.
- 1 participant enrolled.
- Results were posted on the registry 3 years 1 month after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Paradigm Spine
- Sponsor type
- Industry
- Conditions
- Spondylolisthesis; Neurologic Deficits; Kyphosis; Pseudarthrosis
- Interventions
- Dynamic Stabilization System (DSS)
- Participants
- 1
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Continued Access Study of Adefovir Dipivoxil (ADV) for Patients w/Chronic HBV Infection.
“The study stopped due to marketing approval by the FDA.” - A Phase 2, Multicenter, Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Pefcalcitol Ointment, 0.005%, Applied Topically Twice Daily (BID) for 8 Weeks in Adolescent Subjects 12 to < 17 Years of Age With Plaque Psoriasis
“FDA requested us to stop the study” - Medication Use Among American Indians Adults
“The study has not been stopped. The study does not qualify as a clinical trial so it was withdrawn from clinicaltrials.gov.” - Phase Ib/II Study of LY2780301 in Combination With Weekly PACLITAXEL in HER2-metastatic Breast Cancer
“Drug development stopped” - A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors
“Study was prematurely discontinued due to unacceptable toxicity.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.